SHANT BIOTECH: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SHANT BIOTECH
Largest movements
- Cash +€955,191
up €955,191 (+175%), from €545,927 to €1.5m
mainly Contributions, distributions and other (+€11.2m) and Trade debts (+€158,665)
- Tangible fixed assets +€761,754
up €761,754 (+8.8%), from €8.7m to €9.4m
of which Land and buildings: +€608,112
- Contributions +€11.2m
up €11.2m (+17,435%), from €64,000 to €11.2m
- Debts after one year -€9.4m
down €9.4m (-97.9%), from €9.6m to €200,000
- Profit (loss) carried forward -€196,394
down €196,394 (-32.6%), from -€602,934 to -€799,328
- Trade debts +€158,665
up €158,665 (+62.3%), from €254,786 to €413,451
- Gross operating margin -€30,413
down €30,413 (-20.6%), from -€147,705 to -€178,118
- Depreciation +€15,702
up €15,702 (+398%), from €3,943 to €19,645
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,324,464 | €11,037,094 | +€1.7m | +18.4% |
| Fixed assets | 21/28 | €8,684,358 | €9,446,112 | +€761,754 | +8.8% |
| Tangible fixed assets | 22/27 | €8,684,358 | €9,446,112 | +€761,754 | +8.8% |
| Land and buildings | 22 | €8,675,286 | €9,283,398 | +€608,112 | +7.0% |
| Plant, machinery and equipment | 23 | €6,697 | €90,403 | +€83,706 | +1,250% |
| Furniture and vehicles | 24 | €2,375 | €72,311 | +€69,936 | +2,944% |
| Current assets | 29/58 | €640,106 | €1,590,983 | +€950,876 | +149% |
| Amounts receivable within one year | 40/41 | €92,688 | €88,017 | -€4,671 | -5.0% |
| Other amounts receivable | 41 | €92,688 | €88,017 | -€4,671 | -5.0% |
| Cash at bank and in hand | 54/58 | €545,927 | €1,501,118 | +€955,191 | +175% |
| Deferred charges and accrued income | 490/1 | €1,491 | €1,847 | +€356 | +23.9% |
| Total equity and liabilities | 10/49 | €9,324,464 | €11,037,094 | +€1.7m | +18.4% |
| Equity | 10/15 | -€538,934 | €10,423,060 | +€11.0m | |
| Contributions | 10/11 | €64,000 | €11,222,388 | +€11.2m | +17,435% |
| Capital | 10 | €64,000 | €11,222,388 | +€11.2m | +17,435% |
| Issued capital | 100 | €64,000 | €11,222,388 | +€11.2m | +17,435% |
| Profit (loss) carried forward | 14 | -€602,934 | -€799,328 | -€196,394 | -32.6% |
| Amounts payable | 17/49 | €9,863,398 | €614,035 | -€9.2m | -93.8% |
| Amounts payable after more than one year | 17 | €9,608,388 | €200,000 | -€9.4m | -97.9% |
| Financial debts | 170/4 | €9,608,388 | €200,000 | -€9.4m | -97.9% |
| Amounts payable within one year | 42/48 | €255,011 | €414,035 | +€159,024 | +62.4% |
| Trade debts | 44 | €254,786 | €413,451 | +€158,665 | +62.3% |
| Suppliers | 440/4 | €254,786 | €413,451 | +€158,665 | +62.3% |
| Taxes, remuneration and social security | 45 | - | €572 | +€572 | |
| Taxes | 450/3 | - | €572 | +€572 | |
| Other amounts payable | 47/48 | €225 | €11 | -€214 | -95.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,943 | €19,645 | +€15,702 | +398% |
| Other operating charges | 640/8 | €1,750 | €1,961 | +€211 | +12.1% |
| Gross operating margin | 9900 | -€147,705 | -€178,118 | -€30,413 | -20.6% |
| Operating profit (loss) | 9901 | -€153,398 | -€199,724 | -€46,326 | -30.2% |
| Financial income | 75/76B | €1 | €0 | -€1 | -98.2% |
| Recurring financial income | 75 | €1 | €0 | -€1 | -98.2% |
| Financial charges | 65/66B | €214 | €659 | +€446 | +208% |
| Recurring financial charges | 65 | €214 | €659 | +€446 | +208% |
| Profit (loss) for the period before taxes | 9903 | -€153,611 | -€200,383 | -€46,773 | -30.4% |
| Income taxes | 67/77 | - | €1,126 | +€1,126 | |
| Profit (loss) for the period | 9904 | -€153,611 | -€201,509 | -€47,899 | -31.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€153,611 | -€201,509 | -€47,899 | -31.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.